08/01/2024 11:15 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form EFFECT | |
08/01/2024 11:15 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form EFFECT | |
08/01/2024 11:15 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form EFFECT | |
08/01/2024 11:15 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form EFFECT | |
07/19/2024 8:22 AM | eFFECTOR Therapeutics, Inc. (Subject) eFFECTOR Therapeutics (Subject) eFFECTOR Therapeutics, Inc. (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
06/25/2024 7:30 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 4:16 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/24/2024 6:06 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2024 5:45 PM | eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer) eFFECTOR Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:45 PM | eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer) eFFECTOR Therapeutics, Inc. (Issuer) Loewy Caroline M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:23 PM | eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer) eFFECTOR Therapeutics, Inc. (Issuer) Harrington-Smith Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for EFTR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
06/13/2024 5:25 PM | eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer) eFFECTOR Therapeutics, Inc. (Issuer) Ehrlich Christopher B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:35 PM | eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer) eFFECTOR Therapeutics, Inc. (Issuer) Klencke Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:15 PM | Bhatt Elizabeth (Reporting) eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer) eFFECTOR Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:19 PM | eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer) eFFECTOR Therapeutics, Inc. (Issuer) Gallagher Brian M. Jr. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 7:36 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 3:51 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
05/09/2024 3:06 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 3:08 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/26/2024 5:05 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form DEF 14A | |
04/26/2024 5:10 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form DEFA14A | |
04/26/2024 5:14 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form ARS | |
04/16/2024 7:00 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form PRE 14A | |
04/04/2024 7:38 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/04/2024 7:40 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
04/04/2024 7:15 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B5 | |
04/02/2024 11:15 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form EFFECT | |
03/29/2024 1:51 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form POS AM | |
03/28/2024 3:02 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/26/2024 7:57 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/25/2024 3:10 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer) eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |